Papillon Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for PPL-001 for the Treatment of Friedreich’s Ataxia
Industry News
Blog|Sep 16 2024
Meet the Community: Allison Rice
Community
News|Sep 11 2024
Stealth BioTherapeutics Awarded Grant from Friedreich’s Ataxia Research Alliance and FARA Ireland to Develop Investigational Mitochondrial Therapeutic SBT-589 for Friedreich’s Ataxia
FARA News | Industry News | Research
News|Sep 10 2024
Meet the 2024 FARA Fellows
FARA News | Research
Blog|Sep 9 2024
Meet the Community: Anthony Monaco
Community
News|Sep 4 2024
FA Community Conversations Genetic Therapies Webinar: Recording Available on YouTube
Education
Blog|Sep 3 2024
Meet the Community 2: A Closer Look – Shelby Wright
Community
News|Aug 27 2024
FARA Celebrates 16 Years of Funding Adaptive Cycling Equipment Through The Ataxian Athlete Initiative (AAI)
rideATAXIA
Blog|Aug 26 2024
Meet the Community 2: A Closer Look – Richard Brown
Community
News|Aug 22 2024
United Against Ataxia Hill Day 2024 – Registration open!